Myofascial pain syndrome
Conditions
Interventions
Normal Group(Group N):biopsy of normal upper trapezius
Biopsy Group(Group B):Biopsy of TrPs plus injection of long-acting analgetics
Injection Group(Group I):Injection of long-acting analgetics
Sponsors
Qili Hospital of Shandong Universtiy
Eligibility
Sex/Gender
All
Age
20 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. aged 20-65 years; 2. with a dignosed myofascial pain syndrome; 3. whose myofascial trigger points are located in upper trapezius; 4. with chronic pain lasted longer than 2 months; 5. whose skin of injection has no infection; 6. Subjects or their legal guardians have signed informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients' pain is resulted from neoplasm metastasis; 2. Patients suffered from sepsis; 3. Patients suffered from coagulation disorders.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| VAS score (before therapy;3 days/1 week/2 weeks/1month/3months after therapy;yellow value(immunohistochemistry);absorbance at 490 nm(RhoA/Cdc42/Rac1 Elisa);absorbance at 490 nm(RhoA/Cdc42/Rac1 Glisa); | — |
Secondary
| Measure | Time frame |
|---|---|
| Frequency of pneumothorax; | — |
Countries
China
Contacts
Public ContactFeng Qi
Outcome results
None listed